🇺🇸 FDA
Patent

US 11077090

Compounds and compositions and uses thereof

granted A61KA61K31/13A61K31/352

Quick answer

US patent 11077090 (Compounds and compositions and uses thereof) held by PGI Drug Discovery LLC expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PGI Drug Discovery LLC
Grant date
Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
45
CPC classes
A61K, A61K31/13, A61K31/352, A61K31/353, A61K45/06